Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2015, Article ID 703457, 4 pages
http://dx.doi.org/10.1155/2015/703457
Case Report

Evading Capture by Residual Disease Monitoring: Extramedullary Manifestation of JAK2 V617F-Positive Primary Myelofibrosis After Allogeneic Stem Cell Transplantation

1Cancer Molecular Diagnostics, St. James’s Hospital, Dublin 8, Ireland
2Department of Haematology, St. James’s Hospital, Dublin 8, Ireland
3Department of Histopathology, St. James’s Hospital, Dublin 8, Ireland

Received 15 June 2015; Revised 17 July 2015; Accepted 22 July 2015

Academic Editor: Ramon Tiu

Copyright © 2015 Stephen E. Langabeer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Stephen E. Langabeer, James Nolan, Karl Haslam, Lindsey Clarke, Richard Flavin, and Eibhlin Conneally, “Evading Capture by Residual Disease Monitoring: Extramedullary Manifestation of JAK2 V617F-Positive Primary Myelofibrosis After Allogeneic Stem Cell Transplantation,” Case Reports in Hematology, vol. 2015, Article ID 703457, 4 pages, 2015. https://doi.org/10.1155/2015/703457.